Details

Novel Antischizophrenia Treatments

Handbook of Experimental Pharmacology, Band 213

von: Mark A. Geyer, Gerhard Gross
CHF 472.00
Verlag:	Springer
Format:	PDF
Veröffentl.:	01.10.2012
ISBN/EAN:	9783642257582
Sprache:	englisch
Anzahl Seiten:	455

In den Warenkorb

Als Gutschein

Dieses eBook enthält ein Wasserzeichen.

Beschreibungen

Titelbeschreibung

This volume tries to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters also deal with respective experimental and clinical methodology, biomarkers, and translational aspects of drug development. The volume concentrates on reviewing the ongoing research attempting to identify novel treatments for the cognitive deficits and negative symptoms of schizophrenia, which are not treated adequately by current antipsychotic medications.

Inhaltsverzeichnis

<p>Preface.- Clinical instruments to evaluate and guide treatment in schizophrenia.- Cognitive deficits in schizophrenia- Muscarinic mechanisms in psychotic disorders.- Nicotinic mechanisms in psychotic disorders.- GABAergic circuits in schizophrenia: targets for new treatments in schizophrenia.- Inhibitors of glycine transport as potential new treatments in schizophrenia.- The role of glutamate in schizophrenia.- Metabotropic glutamate receptors as targets for new treatments in schizophrenia.- 5-HT2C agonism as a principle for new treatments in schizophrenia.- The role of dopamine D3 receptors for antipsychotic activity and cognitive functions.- Phosphodiesterase inhibitors as potential new treatments in schizophrenia.- Disease modifying approaches to schizophrenia.- A novel therapeutic strategy: medication-enhancement of cognitive therapies in schizophrenia.- Transgenic animals reflecting aspects of schizophrenia.- Behavioral animal models of pro-cognitive treatments for schizophrenia. </p><p>

Sonderbeitrag

Provide up-to-date information on approaches to the discovery of treatments for cognitive deficits in schizophrenia Provide information on promising new targets for therapeutics in the treatment of schizophrenia Describe potential use of adjunctive co-treatments for use together with traditional antipsychotics Includes supplementary material: sn.pub/extras